The popularity of Viagra initially sparked a period of growth for the drug industry, but recent developments present a complicated scenario for shareholders. Generic alternatives are eating into profits, and persistent https://graysonkigq835721.activoblog.com/52290485/the-blue-pill-and-the-pharmaceutical-industry-a-volatile-investment